These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18326078)

  • 21. Head and neck cancer in the elderly: an overview on the treatment modalities.
    Syrigos KN; Karachalios D; Karapanagiotou EM; Nutting CM; Manolopoulos L; Harrington KJ
    Cancer Treat Rev; 2009 May; 35(3):237-45. PubMed ID: 19100689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of advanced head and neck cancer.
    Yalçýn B; Büyükçelik A; Utkan G
    N Engl J Med; 2004 Aug; 351(8):829-31; author reply 829-31. PubMed ID: 15320314
    [No Abstract]   [Full Text] [Related]  

  • 23. Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma.
    Salas S; Deville JL; Giorgi R; Pignon T; Bagarry D; Barrau K; Zanaret M; Giovanni A; Bourgeois A; Favre R; Duffaud F
    Radiother Oncol; 2008 May; 87(2):195-200. PubMed ID: 18342966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biological and clinical prerequisites of radiochemotherapy in neoplasms of the cervicofacial area].
    Tucci E; Capuano A; Pirtoli L; Bonucci I
    Minerva Stomatol; 1987 Nov; 36(11):871-5. PubMed ID: 3323873
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of advanced head and neck cancer.
    Sonpavde G
    N Engl J Med; 2004 Aug; 351(8):829-31; author reply 829-31. PubMed ID: 15320313
    [No Abstract]   [Full Text] [Related]  

  • 26. Major response to paclitaxel combined with irradiation as second-line therapy in metastatic angiosarcoma of the face and scalp.
    Hofmann UB; Wobser M; Kneitz H; Kleine P; Becker JC; Bröcker EB; Ugurel S
    Br J Dermatol; 2009 Feb; 160(2):456-8. PubMed ID: 19077074
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of the Göttingen chemotherapy studies].
    Schröder M; von Heyden HW
    Sonderb Strahlenther Onkol; 1987; 81():99-102. PubMed ID: 3547732
    [No Abstract]   [Full Text] [Related]  

  • 28. Mesenchymal chondrosarcoma: report of a case.
    Yamokoski C; Ahmad K; Kim YH; Fayos JV; Toledano S; Albores-Saavedra J
    J Am Osteopath Assoc; 1986 Sep; 86(9):561-3. PubMed ID: 3095275
    [No Abstract]   [Full Text] [Related]  

  • 29. Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer.
    Rivera F; Eugenia Vega-Villegas M; López C; Francisca López-Brea M; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Hinojo C; Márquez R; Angel Alonso-Bermejo M; Salcedo M; Blanco Y; Vega N; López-Tarruella S; Sanz-Ortiz J
    Acta Oncol; 2008; 47(8):1584-9. PubMed ID: 18607841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of advanced head and neck cancer.
    Fortin A; Audet N; Caouette R
    N Engl J Med; 2004 Aug; 351(8):829-31; author reply 829-31. PubMed ID: 15317900
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State of head and neck surgical oncology research--a review and critical appraisal of landmark studies.
    Higgins KM; Wang JR
    Head Neck; 2008 Dec; 30(12):1636-42. PubMed ID: 18642286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Another look at induction chemotherapy for organ preservation in patients with head and neck cancer.
    Forastiere AA
    J Natl Cancer Inst; 1996 Jul; 88(13):855-6. PubMed ID: 8656431
    [No Abstract]   [Full Text] [Related]  

  • 35. Individualized treatment selection in patients with head and neck cancer: do molecular markers meet the challenge?
    Singh B; Pfister DG
    J Clin Oncol; 2008 Jul; 26(19):3114-6. PubMed ID: 18474877
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas: a retrospective analysis of a monoinstitutional series.
    Welz H; Pöttgen C; Abu Jawad J; Wierlemann A; Wittig A; Stüben G; Budach V; Lehnerdt G; Jahnke K; Sack H; Stuschke M
    Oncology; 2009; 76(6):405-12. PubMed ID: 19407473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of chemotherapy to cure head and neck cancer.
    Taylor SG
    J Infus Chemother; 1995; 5(2):44-5. PubMed ID: 8521233
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjuvant post-operative chemoradiotherapy in head and neck cancer: a standard of care?
    Posner MR
    Oncologist; 2005 Mar; 10(3):174-5. PubMed ID: 15793219
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cytostatic polychemotherapy protocols. I. Neoplasms of the cervicofacial area].
    Bild E; Carasevici E
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(4):755-60. PubMed ID: 3253929
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction chemotherapy in head and neck cancer.
    Haddad RI; Posner MR
    J Clin Oncol; 2009 Aug; 27(23):e52-3; author reply e54. PubMed ID: 19597015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.